Adra N - Search Results

1

A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors.

Adra N, Vaughn DJ, Einhorn LH, Hanna NH, Funt SA, Rosales M, Arozullah A, Feldman DR. Adra N, et al. Invest New Drugs. 2022 Oct;40(5):1087-1094. doi: 10.1007/s10637-022-01276-w. Epub 2022 Jun 27. Invest New Drugs. 2022. PMID: 35759134 Free PMC article. Clinical Trial.

2

Chemotherapy-Related Chronic Myelogenous Leukemia: A Case Series of Patients With Germ Cell Tumor.

Adra N, Sayar H, Einhorn LH. Adra N, et al. JAMA Oncol. 2016 Mar;2(3):391-2. doi: 10.1001/jamaoncol.2015.4837. JAMA Oncol. 2016. PMID: 26632950 Free article. No abstract available.

3

Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.

Adra N, Albany C, Brames MJ, Case-Eads S, Johnson CS, Liu Z, Fausel CA, Breen T, Hanna NH, Hauke RJ, Picus J, Einhorn LH. Adra N, et al. Support Care Cancer. 2016 Jul;24(7):2837-42. doi: 10.1007/s00520-016-3100-y. Epub 2016 Feb 2. Support Care Cancer. 2016. PMID: 26838019 Free article. Clinical Trial.

4

Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014.

Adra N, Althouse SK, Liu H, Brames MJ, Hanna NH, Einhorn LH, Albany C. Adra N, et al. Ann Oncol. 2016 May;27(5):875-9. doi: 10.1093/annonc/mdw045. Epub 2016 Feb 9. Ann Oncol. 2016. PMID: 26861605 Free PMC article.

5

A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors.

Necchi A, Pond GR, Nicolai N, Giannatempo P, Raggi D, Adra N, Hanna NH, Salvioni R, Einhorn LH, Albany C. Necchi A, et al. Among authors: adra n. Clin Genitourin Cancer. 2017 Apr;15(2):306-312.e3. doi: 10.1016/j.clgc.2016.07.022. Epub 2016 Aug 8. Clin Genitourin Cancer. 2017. PMID: 27594554

6

High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience.

Adra N, Abonour R, Althouse SK, Albany C, Hanna NH, Einhorn LH. Adra N, et al. J Clin Oncol. 2017 Apr 1;35(10):1096-1102. doi: 10.1200/JCO.2016.69.5395. Epub 2016 Nov 21. J Clin Oncol. 2017. PMID: 27870561 Free PMC article.

7

TMPRSS2-ERG Fusion in an Uncommon Presentation of Prostate Cancer.

Adra N, Cheng L, Hanna NH, Durm G. Adra N, et al. Clin Genitourin Cancer. 2017 Jun;15(3):e489-e491. doi: 10.1016/j.clgc.2017.01.020. Epub 2017 Feb 1. Clin Genitourin Cancer. 2017. PMID: 28216280 No abstract available.

8

Testicular cancer update.

Adra N, Einhorn LH. Adra N, et al. Clin Adv Hematol Oncol. 2017 May;15(5):386-396. Clin Adv Hematol Oncol. 2017. PMID: 28591093 Review.

9

Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206.

Adra N, Einhorn LH, Althouse SK, Ammakkanavar NR, Musapatika D, Albany C, Vaughn D, Hanna NH. Adra N, et al. Ann Oncol. 2018 Jan 1;29(1):209-214. doi: 10.1093/annonc/mdx680. Ann Oncol. 2018. PMID: 29045540 Free article. Clinical Trial.

10

Salvage therapy for relapsed testicular cancer.

Adra N, Einhorn LH. Adra N, et al. Oncotarget. 2017 Aug 25;8(41):69200-69201. doi: 10.18632/oncotarget.20573. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050196 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters